Top Markets
#1 bitcastle Token bitcastle Token +152.04%
#2 MarsCoin MarsCoin +66.30%
#3 Palladium Network Palladium Network +53.32%
#4 Siren Siren +28.84%
#5 Bedrock Bedrock +22.61%
#6 edgeX edgeX +20.39%
#7 Useless Coin Useless Coin +19.40%
#8 Status Status +16.97%
#9 Asteroid Shiba Asteroid Shiba +16.77%
#10 PondCoin PondCoin +15.92%
Coin of the day
bitcastle Token bitcastle Token
Settings
Language
ENGLISH
Currency
USD
Theme
Alar Pharmaceuticals Inc. Alar Pharmaceuticals Inc.

Alar Pharmaceuticals Inc.

6785
Rank in Stocks #18598
Alar Pharmaceuticals Inc., a drug development company, focuses on developing... Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.
Share Price
$2.88
Market Cap
$192.66M
Change (1 day)
-0.55%
Change (1 year)
-59.61%
Country
TW
Trade Alar Pharmaceuticals Inc. (6785)

Category

Healthcare
Earnings for Alar Pharmaceuticals Inc. (6785)
Earnings in 2026 TTM: 0
According to Alar Pharmaceuticals Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Alar Pharmaceuticals Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$1.21B -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT